4//SEC Filing
Sankar Subramanian 4
Accession 0001808805-22-000097
CIK 0001808805other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:50 PM ET
Size
6.9 KB
Accession
0001808805-22-000097
Insider Transaction Report
Form 4
Sankar Subramanian
Senior VP, Product Development
Transactions
- Purchase
Common Stock
2022-09-15$2.19/sh+40,000$87,752→ 40,000 total - Purchase
Common Stock
2022-09-16$2.16/sh+35,000$75,446→ 75,000 total
Footnotes (2)
- [F1]Represents the weighted average share price of an aggregate total of 40,000 shares purchased in the price range of $2.145 to $2.2292 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 35,000 shares purchased in the price range of $2.10 to $2.21 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001856744
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 5:50 PM ET
- Size
- 6.9 KB